|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: besifloxacin hydrochloride
| |||||||||||||||||||
Clinical Trials for: besifloxacin hydrochlorideSystemic Pharmacokinetics of BOL-303224-A Status: Completed Condition: Conjunctivitis, Bacterial Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects Status: Completed Condition: Cataract Extraction A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Status: Completed Condition: Acute Bacterial Conjunctivitis Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis Status: Terminated Condition: Bacterial Conjunctivitis 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery Status: Completed Condition: Corneal Health; Cataract Surgery Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | BESIVANCE | besifloxacin hydrochloride | SUSPENSION/DROPS; OPHTHALMIC | 022308 | May 28, 2009 | RX | Yes | 5,447,926 | Y | Y | <disabled> | METHOD OF TREATING OCULAR BACTERIAL INFECTIONS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bausch And Lomb | BESIVANCE | besifloxacin hydrochloride | SUSPENSION/DROPS; OPHTHALMIC | 022308 | May 28, 2009 | RX | Yes | 6,685,958 | Y | <disabled> | METHOD OF TREATING OCULAR BACTERIAL INFECTIONS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bausch And Lomb | BESIVANCE | besifloxacin hydrochloride | SUSPENSION/DROPS; OPHTHALMIC | 022308 | May 28, 2009 | RX | Yes | 6,699,492 | Y | <disabled> | METHOD OF TREATING OCULAR BACTERIAL INFECTIONS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bausch And Lomb | BESIVANCE | besifloxacin hydrochloride | SUSPENSION/DROPS; OPHTHALMIC | 022308 | May 28, 2009 | RX | Yes | 8,415,342 | <disabled> | METHOD OF TREATING OCULAR BACTERIAL INFECTIONS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
